Physician profile
Muhammad Mir
NPI 1538460951
$4,015.42
in general payments reported to CMS, 2019-2025
24 companies · $469 in 2025
The $469 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.10 · 2020: $246 · 2021: $717 · 2022: $448 · 2023: $1,586 · 2024: $538 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,339 · Travel and Lodging: $1,184 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,339.13 |
| Travel and Lodging | $1,183.99 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,255.53 | 2023-2024 | Single Use Suction Valve (Sterile), Olympus, Vizishot 2 Flex |
| Glaxosmithkline, LLC. | $576.15 | 2020-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $391.57 | 2020-2025 | Tezspire, Airsupra, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $371.03 | 2019-2025 | Ofev |
| Regeneron Healthcare Solutions, INC. | $302.91 | 2021-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $248.54 | 2021-2025 | Opsumit, Uptravi, Opsynvi |
| Genzyme Corporation | $158.25 | 2021-2025 | |
| Baxter Healthcare | $132.76 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Amgen INC. | $104.52 | 2020-2025 | Tezspire |
| United Therapeutics Corporation | $82.28 | 2020-2021 | |
| Itamar Medical INC | $59.26 | 2023 | Watchpatone |
| Inspire Medical Systems, INC. | $57.53 | 2023 | Inspire |
| Genentech USA, INC. | $52.12 | 2021-2022 | |
| Electromed, INC. | $32.17 | 2021-2022 | |
| Mylan Specialty L.P. | $25.97 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $23.63 | 2025 | Ohtuvayre |
| Insmed, INC. | $21.79 | 2021 | |
| Grifols USA, LLC | $21.79 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.66 | 2023 | Glassia |
| Astellas Pharma US INC | $18.04 | 2021 | |
| Axsome Therapeutics, INC. | $15.01 | 2023 | Sunosi |
| Philips North America LLC | $14.44 | 2023 | |
| Circassia INC. | $14.41 | 2020 | |
| Inogen, INC. | $14.06 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Mir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.